Subscribe to Search results

Dr Craske asked for people with mild haemophilia to be given NHS Factor 8 for non-urgent operations such as tooth extraction, saying "We have found from observations at Oxford that this is the best way of finding out whether the material is associated with cases of hepatitis".

Published on:

Dr Aronstam disagreed with giving mild haemophiliacs NHS Factor 8 for non-urgent operations as he didn't want them to develop hepatitis in any form.

Published on:

Dr Craske suggested a trial of NHS concentrate be made to cover non-urgent operations, where other concentrates such as commercial material would be indicated.

Published on:

At the 17th meeting of the Haemophilia Reference Centre Directors, at which Dr Aronstam was present, the increased use of cryoprecipitate was discussed in the light of the first known death of a haemophiliac in the UK from AIDS.

Published on:

Dr Aronstam switched from using unheated commercial product to using heat treated commercial product (although he continued to use unheat-treated NHS concentrate).

Published on:

Dr Aronstam informed Dr Ahmed a patient had lost movement in both of his elbows and shoulders as a direct consequence of him not treating himself properly due to a fear of contracting AIDS, recording that he had advised the patient of "the very small risk numerically" of him acquiring the disease.

Published on:

In a letter to Dr Barnes, Dr Aronstam discussed concerns raised by Dr Barnes about Factor VIII affecting "T" cells, noting that the risk was very small and should not deflect from providing appropriate treatment.

Published on:

Dr Aronstam wrote to Dr Snape to enquire about a specially accredited pool of Factor 8 donors for new and mild haemophiliacs.

Published on:

Dr Snape wrote to Dr Lane discussing a letter from Dr Aronstam regarding the use of hepatitis-reduced Factor 8 where he highlights his immediate concern being securing Factor 8 for two untreated babies, additionally, he was prepared to enter suitable pupils from the College for a prospective hepatitis-reduced product study.

Published on:

Dr Aronstam wrote to Professor Bloom confirming that a patient was on the accredited donor pool long before heat treatment became available, it was also confirmed that the patient remained HTLV-3 antibody free.

Published on:

Dr Aronstam expressed reservations as to whether it was ethically right in "the current climate" to continue a patients's tolerance inducing protocol.

Published on:

Professor Bloom informed Dr Aronstam that a Treloar's pupil had received some of the same batch as the Cardiff patient who had developed AIDS.

Published on:

Staff at Treloar's indicated to students sitting together in a large room whether they were HIV positive by going around and saying 'yes' or 'no'.

Published on:

Prophylaxis treatment of a patient was discontinued after three years in 1987 because of the risks that immune-suppressive effects would follow.

Published on:

Dr Aronstam stated that reports of a hepatitis outbreak at Treloar's had been overstated.

Published on:

Dr Aronstam stated, in reference to a Treloar's student, that "he is realistic about AIDS and feels as I do that the benefits of treatment far outweigh the small risk of acquiring this condition".

Published on:

Dr Aronstam said to Adrian Goodyear, "we have fucked up, we've messed up, its all gone wrong".

Published on:

Adrian Goodyear and four other Treloar's students were told in Dr Aronstam's office that they had HIV.

Published on:

Adrian Goodyear had a conversation with Dr Aronstam, who stated "we messed up", "AIDS didn't need to happen" and "the PHLS have let me down".

Published on:

Adrian Goodyear recalled that in the early 1980s a small fridge was used for housing NHS material and a larger fridge was used for commercial products.

Published on: